Sangam Health Care Products Limited announced that its Board of Directors has accepted the resignation of Mr. T. Abhilash as Company Secretary and Compliance Officer. The departure takes effect from the close of business hours on September 8, 2026.

Mr. Abhilash tendered his resignation to pursue an alternate career opportunity outside the organisation. The Board placed on record its appreciation for the services rendered by him during his tenure.

Regulatory Disclosure

The company filed the disclosure pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing references Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026.

The Managing Director, D. Bhagat Reddy, signed the communication to the BSE Limited. Mr. Abhilash requested the company to file necessary e-forms with the Registrar of Companies to give effect to the resignation.

Sangam Health Care Products Ltd reported an 88.1% decline in net profit to ₹5.33 lakh for the financial year ended March 31, 2026, down from ₹44.96 lakh in the previous year. The company's revenue from operations fell 9.8% to ₹1,123.33 lakh for FY26, compared to ₹1,245.96 lakh in FY25. The decline in profitability was driven by increased employee benefit expenses and other expenses, which rose to ₹228.68 lakh and ₹277.90 lakh respectively.

The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 29, 2026. The statutory auditors, M M Reddy & Co., issued an audit report with an unmodified opinion on the standalone annual financial results. The audit was conducted in accordance with the Standards on Auditing specified under section 143(10) of the Companies Act, 2013.

For the quarter ended March 31, 2026, the company reported a net loss of ₹27.89 lakh, contrasting with a net profit of ₹18.76 lakh in the same quarter of the previous year. Revenue for the quarter stood at ₹265.50 lakh, slightly higher than the ₹258.17 lakh recorded in the corresponding period of the prior year. Total expenses for the quarter increased to ₹314.99 lakh from ₹261.02 lakh.

The balance sheet as of March 31, 2026, shows total assets at ₹1,122.13 lakh, a decrease from ₹1,134.46 lakh in the previous year. The company's equity and liabilities reflected a negative total equity of ₹(1,984.94) lakh, primarily due to accumulated losses in reserves and surplus amounting to ₹(3,471.01) lakh. Non-current liabilities stood at ₹2,356.31 lakh, while current liabilities were ₹750.76 lakh.

Cash flow from operating activities for FY26 was positive at ₹2.57 lakh, a significant recovery from the negative cash flow of ₹(275.97) lakh in the previous year. However, the company reported a net decrease in cash and cash equivalents of ₹(5.57) lakh during the year, bringing the closing balance to ₹15.17 lakh. The financial statements were prepared in compliance with the Indian Accounting Standards (Ind AS) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Summary